AQUINOX PHARMACEUTICALS INC's ticker is AQXP and the CUSIP is 03842B101. A total of 47 filers reported holding AQUINOX PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.27 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $7,000 | -12.5% | 3,000 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $8,000 | +33.3% | 3,000 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $6,000 | -33.3% | 3,000 | -58.3% | 0.00% | 0.0% |
| Q3 2018 | $9,000 | -74.3% | 7,200 | -37.4% | 0.00% | -66.7% |
| Q2 2018 | $35,000 | -28.6% | 11,500 | +74.2% | 0.00% | -25.0% |
| Q1 2018 | $49,000 | +172.2% | 6,600 | +230.0% | 0.00% | +300.0% |
| Q4 2017 | $18,000 | +800.0% | 2,000 | -65.9% | 0.00% | – |
| Q3 2017 | $2,000 | -71.4% | 5,870 | +11.4% | 0.00% | – |
| Q2 2017 | $7,000 | -91.9% | 5,270 | -94.1% | 0.00% | -100.0% |
| Q1 2017 | $86,000 | +17.8% | 89,600 | +171.9% | 0.00% | +100.0% |
| Q4 2016 | $73,000 | -26.3% | 32,950 | +26.3% | 0.00% | -50.0% |
| Q3 2016 | $99,000 | – | 26,094 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 400,900 | $1,062,000 | 0.78% |
| EMORY UNIVERSITY | 209,207 | $554,000 | 0.37% |
| EcoR1 Capital, LLC | 1,150,000 | $3,048,000 | 0.29% |
| Baker Brothers Advisors | 10,934,154 | $28,976,000 | 0.22% |
| DLD Asset Management, LP | 763,100 | $2,030,000 | 0.15% |
| UNIVERSITY OF NOTRE DAME DU LAC | 214,759 | $569,000 | 0.11% |
| Kalos Management, Inc. | 15,850 | $226,000 | 0.10% |
| SPHERA FUNDS MANAGEMENT LTD. | 257,613 | $683,000 | 0.09% |
| DLD Asset Management, LP | 379,900 | $1,007,000 | 0.08% |
| DLD Asset Management, LP | 379,300 | $1,009,000 | 0.08% |